182 related articles for article (PubMed ID: 8877730)
1. Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
Pesch J; Brehm U; Staib C; Grummt F
J Interferon Cytokine Res; 1996 Aug; 16(8):595-600. PubMed ID: 8877730
[TBL] [Abstract][Full Text] [Related]
2. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.
Santhanam U; Ray A; Sehgal PB
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7605-9. PubMed ID: 1652755
[TBL] [Abstract][Full Text] [Related]
3. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells.
Klein-Hessling S; Schneider G; Heinfling A; Chuvpilo S; Serfling E
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15311-6. PubMed ID: 8986808
[TBL] [Abstract][Full Text] [Related]
4. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
[TBL] [Abstract][Full Text] [Related]
5. The basic carboxy-terminal domain of human p53 is dispensable for both transcriptional regulation and inhibition of tumor cell growth.
Pellegata NS; Cajot JF; Stanbridge EJ
Oncogene; 1995 Jul; 11(2):337-49. PubMed ID: 7624148
[TBL] [Abstract][Full Text] [Related]
6. Overlapping domains on the p53 protein regulate its transcriptional activation and repression functions.
Subler MA; Martin DW; Deb S
Oncogene; 1994 May; 9(5):1351-9. PubMed ID: 8152795
[TBL] [Abstract][Full Text] [Related]
7. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.
Ragimov N; Krauskopf A; Navot N; Rotter V; Oren M; Aloni Y
Oncogene; 1993 May; 8(5):1183-93. PubMed ID: 8479742
[TBL] [Abstract][Full Text] [Related]
8. Signal requirements for interleukin 4 promoter activation in human T cells.
Paliogianni F; Hama N; Mavrothalassitis GJ; Thyphronitis G; Boumpas DT
Cell Immunol; 1996 Feb; 168(1):33-8. PubMed ID: 8599837
[TBL] [Abstract][Full Text] [Related]
9. IL-4 gene transcription in human T cells is suppressed by T-bet.
Kitamura N; Kitamura F; Kaminuma O; Miyatake S; Tatsumi H; Nemoto S; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():68-70. PubMed ID: 17541280
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of Tax-activated human Jurkat leukemia T cells by all-trans retinoic acid requires JNK-1 inhibition.
Parra E; Gutiérrez L
Oncol Rep; 2013 Jan; 29(1):387-93. PubMed ID: 23129057
[TBL] [Abstract][Full Text] [Related]
11. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter.
Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH
J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601
[TBL] [Abstract][Full Text] [Related]
12. Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53.
Angelo LS; Talpaz M; Kurzrock R
Cancer Res; 2002 Feb; 62(3):932-40. PubMed ID: 11830554
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
14. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
[TBL] [Abstract][Full Text] [Related]
15. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
Jenkins F; Cockerill PN; Bohmann D; Shannon MF
J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells.
Yea SS; Yang KH; Kaminski NE
J Pharmacol Exp Ther; 2000 Feb; 292(2):597-605. PubMed ID: 10640296
[TBL] [Abstract][Full Text] [Related]
17. Role of ETS1 in IL-2 gene expression.
Romano-Spica V; Georgiou P; Suzuki H; Papas TS; Bhat NK
J Immunol; 1995 Mar; 154(6):2724-32. PubMed ID: 7876544
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells.
Tsuboi A; Muramatsu M; Tsutsumi A; Arai K; Arai N
Biochem Biophys Res Commun; 1994 Mar; 199(2):1064-72. PubMed ID: 8135780
[TBL] [Abstract][Full Text] [Related]
20. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
